Publications by authors named "Emma Birch"
Article Synopsis
- Researchers studied how using a special type of report called a personalized and patient-centered report (PCR) helps patients understand their prostate cancer diagnosis better after surgery compared to a regular report.
- They invited patients from three clinics to participate and gave them either the PCR or a standard report and then tested how well they remembered important details about their diagnosis.
- The results showed that both groups felt happy with their healthcare experience, but there was no big difference in how much they understood their condition.
Purpose: A Robotic Prostatectomy Care Pathway ("Robocare"), aiming to prepare men for robotic-assisted radical prostatectomy (RARP) and manage side-effects and long-term follow-up in a multidisciplinary fashion was established. The pathway enhances patient care by providing adequate information and support and optimizes efficiency by reducing length of stay and minimizing hospital visits. Our study assesses the pathway for patient satisfaction, co-ordination of care between disciplines, length of stay and readmission rates.
View Article and Find Full Text PDFObjective: To compare the recovery of urinary continence (UC) after robot-assisted radical prostatectomy (RARP) in men aged ≥70 and <70 years at 1-year follow-up and to assess for preoperative predictors of UC recovery, as older, healthy men with localised prostate cancer are often denied curative surgical treatment on the grounds of worse UC recovery.
Patients And Methods: In all, 262 patients with prostate cancer having undergone RARP between May 2008 and September 2012, under the care of two consultant urological surgeons at three Melbourne hospitals, were identified. Patients were categorised based on their age ≥70 and <70 years and compared with regards to two endpoints; percentage fully continent and mean pads/day at 4-6 weeks, and 3, 6, 9 and 12 months after RARP.
Background: The adoption of robotic-assisted partial nephrectomy (RAPN) is increasing in Australia; however, to date no Australian RAPN series has been reported. This paper describes a single-surgeon initial experience with RAPN and evaluates perioperative, pathological and oncological outcomes.
Methods: Data on the first 50 consecutive patients to undergo RAPN by a single surgeon were reviewed.